Serkan Levent

2.9k total citations
122 papers, 2.3k citations indexed

About

Serkan Levent is a scholar working on Organic Chemistry, Pharmacology and Molecular Biology. According to data from OpenAlex, Serkan Levent has authored 122 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Organic Chemistry, 50 papers in Pharmacology and 42 papers in Molecular Biology. Recurrent topics in Serkan Levent's work include Synthesis and biological activity (60 papers), Cholinesterase and Neurodegenerative Diseases (35 papers) and Computational Drug Discovery Methods (29 papers). Serkan Levent is often cited by papers focused on Synthesis and biological activity (60 papers), Cholinesterase and Neurodegenerative Diseases (35 papers) and Computational Drug Discovery Methods (29 papers). Serkan Levent collaborates with scholars based in Türkiye, Italy and Iraq. Serkan Levent's co-authors include Yusuf Özkay, Begüm Nurpelin Sağlık, Zafer Asım Kaplancıklı, Derya Osmani̇ye, Ulviye Acar Çevik, Sinem Ilgın, Betül Kaya Çavuşoğlu, Halise İnci Gül, Özlem Atlı and Abdullah Burak Karaduman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecules and RSC Advances.

In The Last Decade

Serkan Levent

111 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serkan Levent Türkiye 30 1.6k 860 734 618 120 122 2.3k
Begüm Nurpelin Sağlık Türkiye 29 1.8k 1.1× 994 1.2× 695 0.9× 814 1.3× 115 1.0× 136 2.5k
Derya Osmani̇ye Türkiye 26 1.3k 0.8× 593 0.7× 547 0.7× 449 0.7× 105 0.9× 95 1.7k
Yusuf Özkay Türkiye 36 2.8k 1.7× 1.1k 1.3× 1.1k 1.5× 996 1.6× 201 1.7× 175 3.7k
Ulviye Acar Çevik Türkiye 24 1.3k 0.8× 471 0.5× 529 0.7× 438 0.7× 117 1.0× 101 1.7k
Gülberk Uçar Türkiye 30 1.4k 0.8× 888 1.0× 665 0.9× 415 0.7× 70 0.6× 91 2.6k
Angela Stefanachi Italy 23 834 0.5× 510 0.6× 578 0.8× 325 0.5× 54 0.5× 55 1.8k
Adriana Bolasco Italy 40 2.4k 1.5× 1.1k 1.3× 822 1.1× 339 0.5× 99 0.8× 62 3.5k
Arianna Granese Italy 29 1.2k 0.7× 559 0.7× 492 0.7× 182 0.3× 63 0.5× 46 2.0k
Franco Chimenti Italy 31 1.9k 1.1× 748 0.9× 634 0.9× 239 0.4× 72 0.6× 65 2.7k
Kemal Yelekçi Türkiye 22 678 0.4× 270 0.3× 696 0.9× 471 0.8× 35 0.3× 66 1.6k

Countries citing papers authored by Serkan Levent

Since Specialization
Citations

This map shows the geographic impact of Serkan Levent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serkan Levent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serkan Levent more than expected).

Fields of papers citing papers by Serkan Levent

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serkan Levent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serkan Levent. The network helps show where Serkan Levent may publish in the future.

Co-authorship network of co-authors of Serkan Levent

This figure shows the co-authorship network connecting the top 25 collaborators of Serkan Levent. A scholar is included among the top collaborators of Serkan Levent based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serkan Levent. Serkan Levent is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Karaca, Hülya, Murat Kaya, Serkan Levent, et al.. (2024). Metabolic engineering of Saccharomyces cerevisiae for enhanced taxadiene production. Microbial Cell Factories. 23(1). 241–241. 5 indexed citations
4.
Osmani̇ye, Derya, Begüm Nurpelin Sağlık, Serkan Levent, et al.. (2024). Design, Synthesis, and Biological Effect Studies of Novel Benzofuran–Thiazolylhydrazone Derivatives as Monoamine Oxidase Inhibitors. ACS Omega. 9(10). 11388–11397. 2 indexed citations
6.
Levent, Serkan, et al.. (2023). HPLC method for simultaneous quantification of lumacaftor and ivacaftor bulk and pharmaceutical formulations. DergiPark (Istanbul University). 2(3). 109–117.
9.
Osmani̇ye, Derya, Begüm Nurpelin Sağlık, Serkan Levent, et al.. (2022). Synthesis of novel benzothiazole derivatives and investigation of their enzyme inhibitory effects against Alzheimer's disease. RSC Advances. 12(36). 23626–23636. 31 indexed citations
10.
Osmani̇ye, Derya, et al.. (2022). Synthesis of New Pyrimidine‐Triazole Derivatives and Investigation of Their Anticancer Activities. Chemistry & Biodiversity. 19(8). e202200216–e202200216. 17 indexed citations
11.
Osmani̇ye, Derya, Asaf Evrim Evren, Begüm Nurpelin Sağlık, et al.. (2021). Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO‐B dual inhibitors. Archiv der Pharmazie. 355(3). e2100450–e2100450. 31 indexed citations
12.
Osmani̇ye, Derya, et al.. (2021). Synthesis and biological evaluation of novel 1,3,4‐oxadiazole derivatives as anticancer agents and potential EGFR inhibitors. Journal of Heterocyclic Chemistry. 59(3). 518–532. 15 indexed citations
13.
Çelik, İlhami, Brice E. N. Wamba, Léon Azefack Tapondjou, et al.. (2020). Roeperone A, a new tetraoxygenated xanthone and other compounds from the leaves of Hypericum roeperianum Schimp. (Hypericaceae). Natural Product Research. 36(8). 2071–2077. 6 indexed citations
14.
Sağlık, Begüm Nurpelin, Ulviye Acar Çevik, Derya Osmani̇ye, et al.. (2020). Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors. Molecules. 25(18). 4342–4342. 9 indexed citations
15.
Çevik, Ulviye Acar, Begüm Nurpelin Sağlık, Derya Osmani̇ye, et al.. (2020). Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison. Journal of Enzyme Inhibition and Medicinal Chemistry. 35(1). 1657–1673. 41 indexed citations
16.
Çavuşoğlu, Betül Kaya, Begüm Nurpelin Sağlık, Ulviye Acar Çevik, et al.. (2020). Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors. Archiv der Pharmazie. 354(3). e2000273–e2000273. 13 indexed citations
17.
Çevik, Ulviye Acar, Begüm Nurpelin Sağlık, Serkan Levent, et al.. (2019). Synthesis and AChE-Inhibitory Activity of New Benzimidazole Derivatives. Molecules. 24(5). 861–861. 44 indexed citations
18.
Özkay, Yusuf, Derya Osmani̇ye, Serkan Levent, & Begüm Nurpelin Sağlık. (2017). Novel Imidazole Derivatives as Antifungal Agents: Synthesis, Biological Evaluation, ADME Prediction and Molecular Docking Studies. SHILAP Revista de lepidopterología. 663–663. 2 indexed citations
19.
Levent, Serkan, Betül Kaya Çavuşoğlu, Begüm Nurpelin Sağlık, et al.. (2017). Synthesis of Oxadiazole-Thiadiazole Hybrids and Their Anticandidal Activity. Molecules. 22(11). 2004–2004. 15 indexed citations
20.
Karaca, Hülya, Ulviye Acar Çevik, Serkan Levent, et al.. (2017). New Benzimidazole-1,2,4-Triazole Hybrid Compounds: Synthesis, Anticandidal Activity and Cytotoxicity Evaluation. Molecules. 22(4). 507–507. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026